Thursday, September 27th

11:30am – 1:00pm

Current Advances in Colon and Gastric Cancer Therapy

sanofi-aventis CME Satellite Symposium and Lunch

1:15pm - 1:20pm

Introduction and ISGIO Presidential Inauguration

Richard Goldberg, President

1:20pm - 1:25pm

Welcome Remarks by the President

New President

Session 1: Esophageal Cancer

Chairpersons: Thomas D'Amico, Anil Rustgi, Joel Tepper

1:25pm - 1:40pm

Esophageal Cancer

Brian Reid

1:40pm - 1:45pm

Q and A

1:45pm - 2:00pm

Is Radiation Needed in the Treatment of Gastroesophageal Junction Adenocarcinoma?

Joel Tepper

2:00pm - 2:05pm

Q and A

2050pm - 2:25pm

Management of Esophageal Cancer and Barrett's Esophagus

Case Discussion 1:

Surgery for Esophageal Cancer
Thomas D'Amico

Case Discussion 2:

High-Grade Dysplasia: So Many Options
Anil Rustgi

Case Discussion 3:

Chemoradiation Resistance: What Happens Then?
Jaffer Ajani

2:25pm - 2:35pm

Break

2:35pm - 2:55pm

Proffered Papers

The Significance of Thromboembolic Phenomena Occurring Before and During Chemoradiotherapy for Localized Carcinoma of the Esophagus and Gastroesophageal Junction

Eric Tetzlaff

Oxaliplatin Induces the Expression of Genes Involved in Capecitabine Activation: Preliminary Results of a Phase I Pharmacodynamic Study in Esophageal Cancer

Sanjay Vinjamaram

2:55pm - 3:00pm

Multidisciplinary Panel Discussion

Moderator: Bruce Minsky

Panelists: Jaffer Ajani, Thomas D'Amico, Atsushi Ohtsu, Brian Reid, Anil Rustgi, Joel Tepper

Session 2: Pancreatic Cancer

Chairpersons: Hedy Lee Kindler, A.  William Blackstock

3:00pm - 3:15pm

Emerging Molecular Biology of Pancreatic Cancer

Ralph Hruban

3:15pm - 3:20pm

Q and A

3:20pm - 3:35pm

Target Therapy: Future Directions

Philip Philip

3:35pm - 3:40pm

Q and A

3:40pm - 4:00pm

Case Discussions: Localized and Metastatic Pancreatic Cancer

Case Discussion 1:

Advanced First-Line
Hedy Lee Kindler

Case Discussion 2:

Is Radiation Needed Anymore?
A.  William Blackstock

Case Discussion 3:

Second-Line Quandaries
Margaret Tempero

4:00pm - 4:40pm

Proffered Papers

TFF1 is Over Expressed Early in Pancreatic Cancer and Stimulates Cancer Cell Invasion and Stromal Cell Growth and Migration

Thiru Arumugam

Phase I Study of Erlotinib, Bevacizumab and Gemcitabine in Patients With Advanced Pancreatic Cancer

Carlos Gomez-Martin

Tissue Transglutaminase Downregulation Potentiates Gemcitabine Efficacy and Blocks Pancreatic Cancer Growth in vivo

Sushovan Guha

Novel Use of Focal High Dose IMRT for Borderline Resectable Pancreatic Cancer

Stephen Settle

4:40pm - 5:00pm

Panel Discussion

Moderator: Margaret Tempero

Panelists:  Al Benson, A.  William Blackstock, Narikazu Boku, Richard Goldberg, Ralph Hruban, Hedy Lee Kindler, Philip Philip

5:15pm – 7:45pm

Advances and Evolving Role of Targeted Therapy in GIST

Novartis Pharmaceuticals CME Satellite Symposium and Dinner

Friday, September 28th

Session 3: Advanced Colorectal Cancer

Chairpersons: Aimery de Gramont, Daniel Haller

8:00am - 8:15am

New Agents on the Horizon and How to Position Them for Advantage

Leonard Saltz

8:15am - 8:20am

Q and A

8:20am - 8:35am

Curable Metastatic Colorectal Cancer

John Marshall

8:35am - 8:40am

Q and A

8:40am - 9:40am

Case Presentations

Case Presentation 1:

First-Line Quandaries
Richard Goldberg

Case Presentation 2:

Second-Line Quandaries
Al Benson

Case Presentation 3:

Would You Resect the Metastases?
Mark Roh

Case Presentation 4:

Resectable Liver-Only Metastases: What Would You Do?
Michael Choti

9:40am - 10:20am

Proffered Papers

A Randomized Phase II Trial of Irinotecan with Hyaluronan (HYCAMP) versus Irinotecan Alone as Treatment for Patients with Metastatic Colorectal Cancer Who Have Failed 5-Fluorouracil–Based Chemotherapy

Peter Gibbs

Capecitabine and Oxaliplatin (CAPOX) Plus Cetuximab in Patients with Metastatic Colorectal Carcinoma Who Progressed After Oxaliplatin-Based Chemotherapy

Zoran Petrovic

Galectin-3 Mediates Nuclear b-catenin Accumulation and Wnt Signaling in Human Colon Cancer Cells Through Regulation of GSK-b activity

Shumei Song

Price Tag on Progress: Rising Chemotherapy Cost for Colorectal Cancer– Evidence From Medicare Claims Analysis

Jue Wang

10:20am - 10:50am

Panel Discussion

Moderators: Neal Meropol, Yasuhide Yamada

Panelists: Al Benson, Barbara Burtness, Michael Choti, Aimery de Gramont, Richard Goldberg, Daniel Haller, Wasaburo Koizumi, Heinz-Josef Lenz, John Marshall, Edith Mitchell, Mark Roh, Leonard Saltz, Alan Venook

10:50am - 11:10am

Break

11:30am – 1:00pm  

Future Directions in the Management Paradigm for Hepatocellular Carcinoma

Bayer Healthcare/Onyx Pharmaceuticals CME Satellite Symposium and Lunch 

Session 4: Hepatobiliary Cancer

Chairpersons: Alan Venook, Michael Choti

1:00pm - 1:40pm

Case Presentations

Case Presentation 1:

Transplant
Mark Roh

Case Presentation 2:

Advanced Disease
Alan Venook